Kidney organoids reveal redundancy in viral entry pathways during ACE2-dependent SARS-CoV-2 infection
Journal of Virology · 2024
DOI: 10.1128/jvi.01802-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Jessica M Vanslambrouck und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Novo Nordisk Foundation Centre for Stem Cell Medicine (reNEW), Murdoch Children's Research Institute, Melbourne, Australia. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme 2, Kidney, Organoids, SARS-CoV-2. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Victorian Government of Jobs Precincts and Regions, Novo Nordisk Foundation, DHAC | National Health and Medical Research Council (NHMRC).
Abstract (Originalsprache)
With a high incidence of acute kidney injury among hospitalized COVID-19 patients, considerable attention has been focussed on whether SARS-CoV-2 specifically targets kidney cells to directly impact renal function, or whether renal damage is primarily an indirect outcome. To date, several studies have utilized kidney organoids to understand the pathogenesis of COVID-19, revealing the ability for SARS-CoV-2 to predominantly infect cells of the proximal tubule (PT), with reduced infectivity following administration of soluble ACE2. However, the immaturity of standard human kidney organoids represents a significant hurdle, leaving the preferred SARS-CoV-2 processing pathway, existence of alternate viral receptors, and the effect of common hypertensive medications on the expression of ACE2 in the context of SARS-CoV-2 exposure incompletely understood. Utilizing a novel kidney organoid model with enhanced PT maturity, genetic- and drug-mediated inhibition of viral entry and processing factors confirmed the requirement for ACE2 for SARS-CoV-2 entry but showed that the virus can utilize dual viral spike protein processing pathways downstream of ACE2 receptor binding. These include TMPRSS- and CTSL/CTSB-mediated non-endosomal and endocytic pathways, with TMPRSS10 likely playing a more significant role in the non-endosomal pathway in renal cells than TMPRSS2. Finally, treatment with the antihypertensive ACE inhibitor, lisinopril, showed negligible impact on receptor expression or susceptibility of renal cells to infection. This study represents the first in-depth characterization of viral entry in stem cell-derived human kidney organoids with enhanced PTs, providing deeper insight into the renal implications of the ongoing COVID-19 pandemic. IMPORTANCE Utilizing a human iPSC-derived kidney organoid model with improved proximal tubule (PT) maturity, we identified the mechanism of SARS-CoV-2 entry in renal cells, confirming ACE2 as the sole receptor and revealing redundancy in downstream cell surface TMPRSS- and endocytic Cathepsin-mediated pathways. In addition, these data address the implications of SARS-CoV-2 exposure in the setting of the commonly prescribed ACE-inhibitor, lisinopril, confirming its negligible impact on infection of kidney cells. Taken together, these results provide valuable insight into the mechanism of viral infection in the human kidney.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Novo Nordisk Foundation Centre for Stem Cell Medicine (reNEW), Murdoch Children's Research Institute, Melbourne, Australia.
- Department of Paediatrics, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Australia.
- Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Australia.
- Department of Nephrology, Royal Children's Hospital, Melbourne, Australia.
- Australia Regenerative Medicine Institute, Monash University, Melbourne, Victoria, Australia.
- Melbourne Centre for Cardiovascular Genomics and Regenerative Medicine, The Royal Children's Hospital, Melbourne, Australia.
ORCID-Profile: Jessica M Vanslambrouck, Melissa H Little
Förderung
- Victorian Government of Jobs Precincts and Regions
- Novo Nordisk Foundation
- DHAC | National Health and Medical Research Council (NHMRC)
Zitieren
APA
Vanslambrouck, J. M., Neil, J. A., Rudraraju, R., Mah, S., Tan, K. S., Groenewegen, E., Forbes, T. A., Karavendzas, K., Elliott, D. A., Porrello, E. R., Subbarao, K., & Little, M. H. (2024). Kidney organoids reveal redundancy in viral entry pathways during ACE2-dependent SARS-CoV-2 infection. Journal of Virology. https://doi.org/10.1128/jvi.01802-23
Vancouver
Vanslambrouck JM, Neil JA, Rudraraju R, Mah S, Tan KS, Groenewegen E, et al. Kidney organoids reveal redundancy in viral entry pathways during ACE2-dependent SARS-CoV-2 infection. Journal of Virology. 2024. doi:10.1128/jvi.01802-23
BibTeX
@article{Vanslambrouck2024,
author = {Vanslambrouck, Jessica M and Neil, Jessica A and Rudraraju, Rajeev and Mah, Sophia and Tan, Ker Sin and Groenewegen, Ella and Forbes, Thomas A and Karavendzas, Katerina and Elliott, David A and Porrello, Enzo R and Subbarao, Kanta and Little, Melissa H},
title = {Kidney organoids reveal redundancy in viral entry pathways during ACE2-dependent SARS-CoV-2 infection},
journal = {Journal of Virology},
year = {2024},
doi = {10.1128/jvi.01802-23}
}
EUVIMED